Erythropoiesis-Stimulating Agent Use Among Non–Dialysis-Dependent CKD Patients Before and After the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) Using a Large US Health Plan Database

Autor: Thamer, Mae, Zhang, Yi, Kshirsagar, Onkar, Cotter, Dennis J., Kaufman, James S.
Zdroj: In American Journal of Kidney Diseases November 2014 64(5):706-713
Databáze: ScienceDirect